Navigation Links
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Date:2/20/2008

lue of third party asset-backed commercial paper amounted to a loss of $1,184,000 for the quarter and year ended December 31, 2007 and represents a provision recorded on the valuation of asset-backed commercial paper held by the Company. Refer to Liquidity and Capital Resources section for more details.

Foreign exchange loss amounted to $54,000 for the current quarter (gain of $1,130,000 for the year), compared to a gain of $245,000 for the same quarter in the previous year (loss of $280,000 for the year). Foreign exchange gains or losses arise on the movement in foreign exchange rates in relation to the Company's net monetary assets denominated in currencies other than US dollars, which is its functional and reporting currency, and consists primarily of monetary assets and liabilities denominated in Canadian dollars. Foreign exchange gains recognized for the year ended December 31, 2007, are mainly attributable to the strengthening of the Canadian dollar compared to the US dollar during the period.

Other income amounted to $287,000 for the current quarter ($1,274,000 for the year), compared to $282,000 for the same quarter in the previous year ($1,348,000 for the year). Other income consists of non-operating revenue, primarily sub-lease revenue. The 2006 income includes an amount of $293,000 in respect of the recovery of prior years' property taxes.

Share of loss in a company subject to significant influence amounted to nil for the current quarter ($327,000 for the year), compared to $489,000 for the corresponding quarter in the previous year ($2,440,000 for the year). Non-controlling interest amounted to nil for the current quarter ($109,000 for the year), compared to $162,000 for the corresponding quarter in the previous year ($801,000 for the year). These items result from the consolidation of the Company's interest in a holding company (Innodia Holding) that owns shares of Innodia Inc., for which Neurochem is the primary beneficiary. The sh
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
3. Neurochem to present at JPMorgan Healthcare Conference
4. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
5. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
6. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
7. Neurochem reports results for third quarter of fiscal 2007
8. Emageon Reports Fourth Quarter and 2007 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 Ticket Down is ... Concert in 2015. After a phenomenal and highly successful ... "Nashville" will be going out on tour again in 2015 and ... tour gets underway on April 29th in New York City at ... at the Comerica Theatre on May 10th. , Fans of the ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 DrugDev ... Melissa (Liss) Easy was named to the 2015 Philadelphia ... Under 40 list spotlights 40 dynamic, up-and-coming leaders less ... and community involvement. Winners are honored at an awards ... of the Philadelphia Business Journal. , Lyn Kremer, Publisher ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 GenSight, the ... has appointed Sean Fitzgerald, a former technology and financial ... Officer and Interim Chief Financial Officer. , Mr Fitzgerald ... technology innovator, EverFi, backed by Amazon founder and CEO ... Evan Williams. Prior to EverFi, he was a Senior ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
Breaking Medicine News(10 mins):Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2
... Inc.,(OTC Bulletin Board: ENEI) today announced that its ... presentation at the Roth,Capital 20th Annual OC Growth ... February 21st. The conference is being held over ... Dana Point, California. The,conference will feature presentations from ...
... /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that for the year ... million, or 62 cents per share, on revenues of $31.8,million ... cents per share, on,revenues of $27.6 million in the previous ... posted a net loss of $26.8 million, or 28,cents per ...
... interpersonal conflicts had more health problems, study found , , FRIDAY, ... along with others is more than a key to pleasant ... health. , Researchers who studied a survey of almost ... their relatives, friends and neighbors were less likely to report ...
... Webcast on February 21st at 12:00 p.m. Pacific Time ... (Amex: SYI ) announced today that Noah Berkowitz, ... present at,the Roth 20th Annual OC Growth Stock Conference ... (3:00 p.m. Eastern time) at the Ritz,Carlton Hotel in ...
... international study published today finds that some alternative therapies ... choices for managing most common neck pain than many ... best options for relief are exercises, education, neck mobilization, ... such as neck collars and ultrasound are not recommended. ...
... concept that chronic pain is a disease in its ... at physical, psychological, and environmental components of this major ... pain medicine expert. , Michael J Cousins AM, MD, ... Institute at the University of Sydney, Royal North Shore ...
Cached Medicine News:Health News:Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference 2Health News:Westaim announces 2007 year-end results 2Health News:Westaim announces 2007 year-end results 3Health News:Westaim announces 2007 year-end results 4Health News:Westaim announces 2007 year-end results 5Health News:Westaim announces 2007 year-end results 6Health News:Westaim announces 2007 year-end results 7Health News:Westaim announces 2007 year-end results 8Health News:Westaim announces 2007 year-end results 9Health News:Westaim announces 2007 year-end results 10Health News:Westaim announces 2007 year-end results 11Health News:Westaim announces 2007 year-end results 12Health News:Unlike Fine Wine, Crabby People Don't Age Well 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 3Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:7-year neck pain study sheds light on best care 2Health News:7-year neck pain study sheds light on best care 3Health News:7-year neck pain study sheds light on best care 4Health News:Chronic pain should be considered a disease 2
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
(Date:3/27/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... registered offering of common shares in the ... Offering, the Company issued 7,286,432 common shares at a ... of approximately $1.45 billion. On March 18, 2015, the ... a final prospectus supplement to its effective shelf registration ...
(Date:3/27/2015)... HOLLYWOOD, Calif. , March 27, 2015 ... of life of myeloma patients while working toward prevention ... Higgins (D-NY) for introducing a federal resolution (H. ... of March 2015 as "National Multiple Myeloma Awareness Month." ... living with myeloma worldwide, and more than 110,000 new ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... NEW YORK , June 24 Reportlinker.com announces that a new market research ... , Global Bipolar Disorder ... http://www.reportlinker.com/p0209267/Global-Bipolar-Disorder-Industry.html , ... This report analyzes the worldwide markets for Bipolar Disorder in US$ Million. The report ...
... ALEXANDRIA, Egypt and NORCROSS, Ga. , June ... distribution company, today announced that it has signed an exclusive agreement ... Pharmaplast. , , , ... milestone agreement is the foundation for MediPurpose,s recently launched Wound Care ...
Cached Medicine Technology:Reportlinker Adds Global Bipolar Disorder Industry 2Reportlinker Adds Global Bipolar Disorder Industry 3Reportlinker Adds Global Bipolar Disorder Industry 4Reportlinker Adds Global Bipolar Disorder Industry 5Reportlinker Adds Global Bipolar Disorder Industry 6Reportlinker Adds Global Bipolar Disorder Industry 7Reportlinker Adds Global Bipolar Disorder Industry 8Reportlinker Adds Global Bipolar Disorder Industry 9Reportlinker Adds Global Bipolar Disorder Industry 10Reportlinker Adds Global Bipolar Disorder Industry 11Reportlinker Adds Global Bipolar Disorder Industry 12Reportlinker Adds Global Bipolar Disorder Industry 13Reportlinker Adds Global Bipolar Disorder Industry 14Reportlinker Adds Global Bipolar Disorder Industry 15Reportlinker Adds Global Bipolar Disorder Industry 16MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 2MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 3MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 4
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: